Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis is a research paper published in Cell chemical biology (2021). On theSindex it has a DataRank of 0. It has been cited 59 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Michigan Institute for Clinical and Health Research
Grant: U069943
National Science Foundation
Grant: 1605266
National Science Foundation
Grant: CBET 1159943
National Science Foundation
Grant: 1813963
National Institutes of Health
Grant: NR-5294
National Institutes of Health
Grant: NR-52281
National Institutes of Health
Grant: R35GM136300
National Institutes of Health
Grant: R01AG050598
National Institutes of Health
Grant: U54GM103297
National Institutes of Health
Grant: R01 AI 151588 01
National Institutes of Health
Grant: R21AI152865
National Institutes of Health
Grant: RF1AG059723
NIAID NIH HHS
Grant: R01 AI151588
University of Michigan
Centers for Disease Control and Prevention
National Institute of Allergy and Infectious Diseases
FWCI
2.41
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Studying the characteristics of nanobody CDR regions based on sequence analysis in combination with 3D structures
Additional file 1 of Studying the characteristics of nanobody CDR regions based on sequence analysis in combination with 3D structures